Viewing nowDSO Tablet 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 201601693 · Approved 2016.03.30 · Insurance code 642706380
Treatment of acid-related disorders (e.g., reflux and ulcers), gastrointestinal disorders caused by anti-inflammatory analgesics, and Helicobacter pylori eradication
This medication is used for the treatment of gastroesophageal reflux disease and related esophagitis, as well as the prevention of recurrence. It also helps in the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It effectively treats short-term gastrointestinal symptoms that may occur during the use of non-steroidal anti-inflammatory drugs, and is effective for the treatment and prevention of gastric ulcers in long-term users. It is also used in the treatment of Zollinger-Ellison syndrome and is utilized as maintenance therapy following the prevention of rebleeding from gastric or duodenal ulcers. This drug is highly effective for the treatment and alleviation of symptoms related to gastrointestinal diseases.
This drug should be swallowed with a liquid such as water and should not be chewed or crushed. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent relapse in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. - Once symptoms have resolved, subsequent recurring symptoms can be controlled by administering 20 mg once daily. - In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continued nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment duration is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. Subsequent doses should be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. 6) Maintenance therapy following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older — Once symptoms have resolved, subsequent recurring symptoms can be controlled by administering 20 mg once daily. Adolescents aged 12 years and older — In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Children under 12 years of age — There is no experience with administration of this drug to children under 12 years of age.
This medication should not be used in patients who have hypersensitivity to specific ingredients or a history of allergies. Care should be taken, especially in patients with allergies to penicillin or macrolide antibiotics, or those on specific cardiovascular medications. Nursing mothers and patients with a history of myocardial infarction should not take this medication. This drug contains a dye called Yellow No. 5, which should be used cautiously in patients sensitive to this component. Rarely, various side effects such as blood abnormalities, allergic reactions, electrolyte imbalances, neuropsychiatric disturbances, and gastrointestinal disorders may occur during use. Regular check-ups are important to monitor health status during long-term use. This medication can suppress gastric acid secretion, thereby increasing the risk of certain bacterial infections; medical advice should be sought if diarrhea persists. Also, long-term use may increase the risk of fractures; caution is needed for patients at risk of osteoporosis. This drug may interact with multiple medications; anyone on other medications should consult a doctor or pharmacist. Safety data is limited during pregnancy; it should be used cautiously when necessary, and is not recommended while breastfeeding. There is no specific antidote for overdose; seek immediate medical attention for appropriate treatment. Keep out of reach of children, and take care not to transfer to other containers.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening of depression, muscle hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, worsening of migraine, sleep disturbances, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, angioedema, otitis media, abnormal olfaction, loss of taste, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, malignancy symptoms, cutaneous lupus erythematosus, systemic lupus erythematosus, myalgia, elevation of creatine kinase, elevated serum and urinary myoglobin, rhabdomyolysis, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, maintaining a storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage will help to maintain the drug's effectiveness for longer periods.
Pale pink, rectangular film-coated tablets
28 tablets (14 tablets/Alu-Alu x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.